Dai-ichi Life Insurance Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.74M | Sell |
94,663
-24,302
| -20% | -$1.42M | 0.16% | 133 |
|
|
2025
Q4 | $6.42M | Hold |
118,965
| – | – | 0.17% | 125 |
|
|
2025
Q3 | $5.37M | Buy |
118,965
+5,068
| +4% | +$237K | 0.13% | 154 |
|
|
2025
Q2 | $5.27M | Buy |
113,897
+40,712
| +56% | +$2M | 0.15% | 145 |
|
|
2025
Q1 | $4.46M | Hold |
73,185
| – | – | 0.13% | 165 |
|
|
2024
Q4 | $4.14M | Buy |
73,185
+6,988
| +11% | +$390K | 0.11% | 183 |
|
|
2024
Q3 | $3.43M | Buy |
66,197
+50,000
| +309% | +$2.35M | 0.09% | 206 |
|
|
2024
Q2 | $673K | Sell |
16,197
-15,055
| -48% | -$674K | 0.02% | 404 |
|
|
2024
Q1 | $1.69M | Sell |
31,252
-7,331
| -19% | -$373K | 0.04% | 319 |
|
|
2023
Q4 | $1.98M | Sell |
38,583
-345,538
| -90% | -$18.1M | 0.04% | 303 |
|
|
2023
Q3 | $22.3M | Sell |
384,121
-64,029
| -14% | -$3.92M | 0.49% | 41 |
|
|
2023
Q2 | $28.7M | Sell |
448,150
-26,477
| -6% | -$1.78M | 0.6% | 34 |
|
|
2023
Q1 | $32.9M | Buy |
474,627
+23,472
| +5% | +$1.66M | 0.72% | 19 |
|
|
2022
Q4 | $32.5M | Buy |
451,155
+112,346
| +33% | +$8.47M | 0.75% | 24 |
|
|
2022
Q3 | $24.1M | Buy |
338,809
+5,364
| +2% | +$389K | 0.59% | 32 |
|
|
2022
Q2 | $25.7M | Buy |
333,445
+71,464
| +27% | +$5.44M | 0.57% | 34 |
|
|
2022
Q1 | $19.1M | Buy |
261,981
+51,603
| +25% | +$3.46M | 0.31% | 76 |
|
|
2021
Q4 | $13.1M | Sell |
210,378
-27,551
| -12% | -$1.62M | 0.17% | 116 |
|
|
2021
Q3 | $14.1M | Sell |
237,929
-27,011
| -10% | -$1.78M | 0.18% | 105 |
|
|
2021
Q2 | $17.7M | Buy |
264,940
+22,160
| +9% | +$1.44M | 0.22% | 89 |
|
|
2021
Q1 | $15.3M | Sell |
242,780
-9,584
| -4% | -$596K | 0.21% | 85 |
|
|
2020
Q4 | $15.7M | Buy |
252,364
+9,364
| +4% | +$576K | 0.23% | 77 |
|
|
2020
Q3 | $14.7M | Buy |
243,000
+24,328
| +11% | +$1.46M | 0.26% | 70 |
|
|
2020
Q2 | $12.9M | Sell |
218,672
-2,885
| -1% | -$173K | 0.29% | 65 |
|
|
2020
Q1 | $12.3M | Sell |
221,557
-49,852
| -18% | -$3.05M | 0.47% | 51 |
|
|
2019
Q4 | $17.4M | Buy |
271,409
+93,744
| +53% | +$5.37M | 0.39% | 62 |
|
|
2019
Q3 | $9.01M | Buy |
177,665
+2,110
| +1% | +$99.2K | 0.22% | 107 |
|
|
2019
Q2 | $7.96M | Sell |
175,555
-252,549
| -59% | -$11.8M | 0.19% | 123 |
|
|
2019
Q1 | $20.4M | Buy |
428,104
+221,679
| +107% | +$11M | 0.5% | 43 |
|
|
2018
Q4 | $10.7M | Sell |
206,425
-10,820
| -5% | -$581K | 0.29% | 88 |
|
|
2018
Q3 | $13.5M | Sell |
217,245
-2,687
| -1% | -$159K | 0.29% | 84 |
|
|
2018
Q2 | $12.2M | Sell |
219,932
-20,247
| -8% | -$1.09M | 0.29% | 82 |
|
|
2018
Q1 | $15.2M | Sell |
240,179
-8,279
| -3% | -$533K | 0.31% | 70 |
|
|
2017
Q4 | $15.2M | Sell |
248,458
-3,689
| -1% | -$231K | 0.3% | 66 |
|
|
2017
Q3 | $16.1M | Sell |
252,147
-775
| -0.3% | -$45.3K | 0.34% | 57 |
|
|
2017
Q2 | $14.1M | Sell |
252,922
-59,286
| -19% | -$3.23M | 0.31% | 62 |
|
|
2017
Q1 | $17M | Buy |
312,208
+14,542
| +5% | +$798K | 0.46% | 41 |
|
|
2016
Q4 | $17.4M | Buy |
+297,666
| New | +$16.3M | 0.52% | 40 |
|
Other funds holding BMY
VCM
VPM
Dai-ichi Life Insurance Company's BMY Position: Q1 2026 in Review
Dai-ichi Life Insurance Company reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, selling an estimated $1.42M and leaving 94,663 shares worth $5.74M. The position accounts for 0.16% of the portfolio, ranked #133.
Dai-ichi Life Insurance Company first reported a position in BMY in Q4 2016 and has held it in 38 quarters since. The position peaked at $32.9M in Q1 2023. 2,523 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Dai-ichi Life Insurance Company held 94,663 shares of Bristol-Myers Squibb worth $5.74M as of Q1 2026.
- Dai-ichi Life Insurance Company sold 24,302 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.42M.
- Bristol-Myers Squibb made up 0.16% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #133 holding.
- Dai-ichi Life Insurance Company first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 38 quarters since.
- Dai-ichi Life Insurance Company's Bristol-Myers Squibb position peaked at $32.9M in Q1 2023.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.